Claim 55% Off TipRanks
- Unlock hedge fund-level data and powerful investing tools for smarter, sharper decisions
- Discover top-performing stock ideas and upgrade to a portfolio of market leaders with Smart Investor Picks
Aimei Health Technology Co., Ltd ( (AFJK) ) just unveiled an announcement.
On April 7, 2026, Aimei Health Technology Co., Ltd deposited $34,330.96 into its trust account, enabling a one-month extension of the deadline to complete its initial business combination from April 6, 2026 to May 6, 2026, marking the seventeenth permitted extension. This latest extension underscores the company’s continued efforts to finalize a merger with United Hydrogen Group Inc. while preserving value for public shareholders through incremental funding of the trust.
In connection with the extension, Aimei issued an unsecured, non-interest-bearing promissory note for $34,330.96 to its sponsor Aimei Health Ltd and United Hydrogen Group Inc., with each party contributing half of the funding. The note, repayable upon completion of the proposed business combination with United Hydrogen, can be optionally converted into private units at $10.00 per unit, aligning the interests of the sponsor and target with the successful closing of the transaction.
More about Aimei Health Technology Co., Ltd
Aimei Health Technology Co., Ltd is a Cayman Islands-incorporated special purpose acquisition company focused on completing an initial business combination, currently targeting a merger with United Hydrogen Group Inc. The company maintains a trust account for the benefit of its public shareholders while it seeks to consummate this transaction.
Average Trading Volume: 12,448
Technical Sentiment Signal: Buy
Current Market Cap: $154M
For a thorough assessment of AFJK stock, go to TipRanks’ Stock Analysis page.